• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inmed Pharmaceuticals Inc (NQ: INM )

    0.2250 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Inmed Pharmaceuticals Inc

    < Previous 1 2
    ...
    8 9 10 11 12 13 14 15 Next >
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
    Via Investor Brand Network
    InMed Pharmaceuticals Committed To Growing Market Reach, Product Portfolio
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.   
    Via Benzinga
    InMed Pharmaceuticals (NASDAQ: INM) Committed to Growing Market Reach, Product Portfolio
    Via Investor Brand Network
    Topics Intellectual Property Supply Chain
    Exposures Intellectual Property Supply Chain
    BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio
    Via Investor Brand Network
    Topics Intellectual Property Supply Chain
    Exposures Intellectual Property Supply Chain
    63 Biggest Movers From Yesterday
    Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet... 
    Via Benzinga
    InMed Pharmaceuticals Makes Changes In Management
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
    Via Benzinga
    InMed Pharmaceuticals (NASDAQ: INM) Makes Changes in Management
    Via Investor Brand Network
    InMed Launching Additional Rare Cannabinoids In Response To Demand
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
    Via Benzinga
    InMed (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Demand
    Via Investor Brand Network
    Topics Supply Chain
    Exposures Supply Chain
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
    Via CannabisNewsWire
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
    Via Investor Brand Network
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
    Via CannabisNewsWire
    Topics Supply Chain
    Exposures Supply Chain
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
    Via Investor Brand Network
    Topics Supply Chain
    Exposures Supply Chain
    InMed Pharmaceuticals Inc. (NASDAQ: INM) Featured in Virtual Coverage of the 34th Annual Roth Conference
    Via Investor Brand Network
    BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference
    Via Investor Brand Network
    InMed Pharmaceuticals Expanding Portfolio In Rare Cannabinoid Market
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
    Via Benzinga
    InMed Pharmaceuticals (NASDAQ: INM) Expanding Portfolio in Rare Cannabinoid Market
    Via Investor Brand Network
    Topics Supply Chain
    Exposures Supply Chain
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market
    Via CannabisNewsWire
    Topics Supply Chain
    Exposures Supply Chain
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market
    Via Investor Brand Network
    Topics Supply Chain
    Exposures Supply Chain
    Stocks That Hit 52-Week Lows On Wednesday
    Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
    Via Benzinga
    InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market
    Via CannabisNewsWire
    InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market
    Via Investor Brand Network
    InMed's Evolution To Commercial Sales Featured In Research Report
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
    Via Benzinga
    InMed’s (NASDAQ: INM) Evolution to Commercial Sales Featured in Research Report
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Evolution to Commercial Sales to Health and Wellness Market Featured in Research Report
    Via Investor Brand Network
    Exposures Product Safety
    InMed Names BayMedica VP Of Sales, Releases Q2 2022 Report
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
    Via Benzinga
    InMed (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
    Via Investor Brand Network
    Topics Intellectual Property Supply Chain
    Exposures Intellectual Property Supply Chain
    InMed Pharmaceuticals (INM): Generating Commercial Sales of CBC and CBT
    LONDON, UK / ACCESSWIRE / February 16, 2022 / InMed Pharmaceuticals' (INM's) Q222 financial results reflect its evolution from a pure-play biotech firm to one with commercial sales to the health and... 
    From Edison Investment Research Limited
    Via AccessWire
    Exposures Product Safety
    InMed Positioned To Offer Rare Cannabinoid Manufacturing Technologies
    This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
    Via Benzinga
    BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
    Via Investor Brand Network
    Topics Intellectual Property Supply Chain
    Exposures Intellectual Property Supply Chain
    < Previous 1 2
    ...
    8 9 10 11 12 13 14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.